0001752724-23-020322.txt : 20230208 0001752724-23-020322.hdr.sgml : 20230208 20230208105135 ACCESSION NUMBER: 0001752724-23-020322 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 EFFECTIVENESS DATE: 20230208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAINSTAY FUNDS TRUST CENTRAL INDEX KEY: 0001469192 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22321 FILM NUMBER: 23597618 BUSINESS ADDRESS: STREET 1: 51 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212 576 7000 MAIL ADDRESS: STREET 1: 51 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10010 0001469192 S000045768 MainStay Cushing MLP Premier Fund C000142690 Class A CSHAX C000142691 Class C CSHCX C000142692 Class I CSHZX C000142693 Investor Class CSHNX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001469192 XXXXXXXX 811-22321 false false false N-1A S000045768 C000142690 C000142692 C000142693 C000142691 MAINSTAY FUNDS TRUST 811-22321 0001469192 549300SQRLBSUG7RD002 51 MADISON AVE New York 10010 US-NY US 212-576-7000 JPMorgan Chase Bank, N.A. 4 Chase Metrotech Center Brooklyn 11245 718-242-0609 Records relating to its functions as custodian, sub-administrator and accounting agent N N N-1A 33 Y Alan R. Latshaw 000000000 N Karen Hammond 000000000 N Jacques P. Perold 000000000 N Susan B. Kerley 000000000 N David H. Chow 001401207 N Richard S. Trutanic 000000000 N Kevin M. Gleason 000000000 30 Hudson Street Jersey City 07302 XXXXXX Y N N N N N NYLIFE Distributors LLC 8-46655 000035350 00000000000000000000 Y N KPMG LLP 185 5493003PVCIGA21K0K42 N N N N N N MainStay Cushing MLP Premier Fund S000045768 549300ESFNCM867SRU33 N 6 0 0 N/A Y N N N N/A 0.00000000 0.00000000 Rule 18f-4 (17 CFR 270.18f-4) Rule 32a-4 (17 CFR 270.32a-4) Rule 22d-1 (17 CFR 270.22d-1) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Rule 15a-4 (17 CFR 270.15a-4) Y N N N New York Life Investment Management LLC 801-57396 000109591 IGJ1X7QLRC5K7CY9GE11 N Cushing Asset Management LP 801-63255 000131517 549300J4XZOND2340P82 N N NYLIM Service Company LLC 084-05844 00000000000000000000 Y N DST Asset Manager Solutions, Inc. 84-00896 00000000000000000000 N Y N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 LEI Number N N JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Royal Bank of Canada ES7IP3U3RHIGC71XBU11 CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N DST Asset Manager Solutions, Inc. 84-00896 SEC File Number N N NYLIM Service Company LLC 084-05844 SEC File Number Y N N New York Life Investment Management LLC IGJ1X7QLRC5K7CY9GE11 Y N JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 N Y N NYLIFE Securities LLC 8-15517 000005167 00000000000000000000 0.00000000 NYLIFE Distributors LLC 8-46655 000035350 00000000000000000000 0.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 64565.40000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 24946.16000000 Barclays Capital, Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 31056.28000000 RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 26793.28000000 Goldman Sachs & Co. LLC 8-00129 000000361 FOR8UP27PHTHYVLBNG30 295901.60000000 UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 30733.76000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 57793.18000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 102964.28000000 National Financial Services LLC 8-26740 000013041 549300JRHF1MHHWUAW04 123708.33000000 Citigroup Global Markets Inc. 8-08177 000007059 MBNUM2BPBDO7JBLYG310 21968.40000000 899516.07000000 Citigroup Global Markets Inc. 8-08177 000007059 MBNUM2BPBDO7JBLYG310 9412933.55000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 343088227.88999999 352501161.44000000 Y 702321081.00000000 Uncommitted 100000000.00000000 N Committed 600000000.00000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 MainStay_Funds_Trust_NCEN.txt REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Report of Independent Registered Public Accounting Firm To the Shareholders of the Fund and Board of Trustees MainStay Funds Trust: In planning and performing our audit of the financial statements of MainStay Cushing MLP Premier Fund (the Fund), one of the funds comprising MainStay Funds Trust, as of and for the year ended November 30, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. Management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of November 30, 2022. This report is intended solely for the information and use of the management and the Board of Trustees of the MainStay Funds Trust, and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ KPMG LLP Philadelphia, Pennsylvania January 25, 2023